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DETERMINATION OF THE STRUCTURE OF
PROTEINS: STUDIES ON RIBONUCLEASE*
STANFORD MOORE

AND

WILLIAM H. STEIN

The Rockefeller Institute for Medical Research,
New York, New York

T

HE most recent Harvey Lecture that dealt to a considerable
degree with the present subject, the chemical structure of pro
teins, was delivered in 1935 by our former chief, the late Dr.
Max Bergmann. 1 At that time, as a result of the efforts of many
investigators, Dr. Bergmann himself included, proteins had come
to be recognized as large molecules built up of hundreds of amino
acid residues of about eighteen varieties joined to one another by
peptide bonds to form long peptide chains. The peptide bonds,
formed by the elimination of a molecule of water between the
amino group of one amino acid and the carboxyl group of the
next, are separated by -CH:: groups that bear the side chains of
the amino acids. The side chains in a protein may be aliphatic,
aromatic, or heterocyclic; they may contain a hydroxyl, a sulfhydryl,
or a thio-ether group; they may be neutral, basic, or acidic. It has
been generally believed that it is primarily the difference in the
nature and arrangement of these groups that determines the
physical, the chemical, and the biological properties 0f each in
dividual protein.
There are two principal aspects of the structure of proteins to
be considered: the chemical composition of the molecule, with
which we are concerned in this discussion, and the physical struc
ture, or orientation of the atoms in space, knowledge of which is
also essential to a full understanding of proteins and enzymes and
how they function.
Although the questions posed by the chemical structure of pro
teins were recognized for many decades, it has been only within
the past ten years that the evolution of new techniques has made
possible rapid progress toward the solution of some of these prob* Lecture delivered February 21, 1957
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lems. Beginning with the introduction of the chromatographic
method into protein chemistry by Martin and Synge, and aided
by countercurrent distribution, as developed by Craig, and zone
electrophoresis, as devised by Wieland, Durrum, and Tiselius and
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FIG. 1. The structure of oxytocin from beef pituitary glands ( du Vigneaud
and associates2 ).

Kunkel, knowledge of peptides and proteins has been accumulat
ing at an increasing rate. One important milestone is the synthesis
of the peptide hormones vasopressin and oxytocin by du Vigneaud
and his group, an accomplishment described in a Harvey Lecture
two years ago. 2 In Fig. 1 is shown the formula of bxytocin, a
peptide containing 9 amino acid residues and possessing a molecu
lar weight of 1007. The full chemic!'l-1 structure of the side chains
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of the amino acids can be represented in the figure, as can the
location of the disulfide bond that holds the peptide chain in the
form of a ring. When much larger molecules are portrayed, the
formulas of the amino acids usually need to be abbreviated, as is
now customary, by the use of the first three letters of their names,
in the manner indicated in the lower part of the figure. Du
Vigneaud's research has many facets of interest, but of particular
significance for the subject of this lecture is the fundamental sup
port that it has furnished for the peptide theory. The structure of
the hormone was deduced from degradative experiments, and a
peptide possessing this structure was synthesized and found to
exhibit full biological activity.
Another classic achievement is the elucidation, by Sanger and
his colleagues, 3• of the chemical structure of insulin, a protein of
51 amino acid residues and a molecular weight of 5733. The
formula, which has been derived through research carried out over
the past ten years, is shown in Fig. 2 in abbreviated form. Insulin
is the largest complex organic molecule for which a structural
formula can be written. Sanger's brilliant achievement has been
followed by several notable advances in other laboratQries. These
include the working out of the structure of the adrenocorticotropic
hormones (ACTH), which have 39 residues, by Bell and asso
ciates,5 Li et aJ,.,6• 7 and White and Landmann; 8 the determination
of the structure of glucagon, which has 29 residues, by Behrens
and colleagues; 9 and the elucidation of the structure of the mela
nocyte stimulating hormone, which has 18 residues, by Harris and
Roos, 10 and Geschwind, Li, and Barnafi.11 Structural analysis of
the more typical proteins having molecular weights in the range
10,000 to 100,000 still lies ahead. Even this goal is in sight, how
ever, and in order to illustrate how it may be approached, we
should like to take you with us as far as we have gone toward
unraveling the structure of one such protein of 124 amino acid
residues, the enzyme ribonuclease.
At the outset, it is a pleasure to emphasize the fact that this re
search has been carried out jointly with Dr. C. H. W. Hirs.
Through his extensive and skillful experimentation, he is directly
responsible for a large part of the data on the structure of ribo
nuclease presented in this lecture.
4
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Ribonuclease was first described in 1920 by Jones,1 2 who
showed that there was present in beef pancreas a relatively heat
stable enzyme, capable of digesting yeast nucleic acid. Dubos and
Thompson13 partially purified the enzyme some eighteen years
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4

later, and in 1940, Kunitz14 described the isolation of bovine
ribonuclease in crystalline form. It proved to be a relatively small
molecule as proteins go, having a molecular weight of about
14,000. The isoelectric point was shown to be near pH 8, and the
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analyses of Brand15 revealed the presence of all of the usual amino
acids, with the significant exception of tryptophan. Recently the
specificity of the enzyme has been studied in several laboratories,
notably those of Todd, of Cohn, and of Markham,cus and it has
been found to hydrolyze the large nucleic acid molecule at the
phosphate bond of pyrimidine, but not of purine nucleotides
(Fig. 3). For precise work it is preferable to use substrates of
lower molecular weight than RNA and of known structure, and

NH

. I

#c ,
NI' CH

I

O=C

tto7yo
c, H
I ,1

II

'\.

��

\

.

2

l'uPine · R1bose

\?tt
p

g\

/CH

H /C
1,,- I

H c--c H
I

J>yrimidine·Ribo5e

. \ OH
\I

p
II

o �I --------o�
+
".
P

,f' "-.
0

OH

Cytidine-2� 3'-cyc1ic

1'ho.5phate

J>ur>ine · Ribose
\

'Ribonucleic Acid

3. The enzymatic specificity of ribonuclease.16 The types of phosphate ester
bonds of pyrimidine nucleotides cleaved by the enzyme are indicated by the
dashed line.
FIG.

fortunately it has been found that ribonuclease hydrolyzes the ester
phosphate bond in the simple synthetic pyrimidine nucleotides,
2',3'-cyclic cytidylic and uridylic acids, as illustrated in Fig. 3.
All of these properties of ribonuclease rendered it a favorable
protein for structural analysis. Since such research is not possible
unless there is available a highly purified preparation of the pro
tein with which to work, it is fortunate that ribonuclease has been
one of the first proteins the homogeneity of which has been
studied by the improved chromatographic techniques devised in
the last decade. Martin and Porter11 in England employed liquid-
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liquid chromatography for this purpose, and Dr. Hirs in our
laboratory used columns of the polycarboxylic acid resin, IRC-50. 18
Both methods of chromatography were capable of removing de
tectable amounts of impurity from crystalline ribonuclease. Evi
dence was also obtained for the occurrence in pancreas of a small
amount of a second protein possessing ribonuclease activity. The
predominant enzyme, ribonuclease A, was prepared in chromato
graphically homogeneous form, as can be seen in Fig. 4, and it is
this purified preparation that furnished the starting material for

10

20

:Eff1uent volume, cc.

Frn. 4. Chromatographic homogeneity of a sample of bovine ribonuclease A
prepared by passage over IRC-50.18 Chromatography was performed with a
0.9 X 30-cm. column of the polycarboxylic acid resin and with phosphate buffer
at pH 6.47 as the eluent.

the next step in the structural analysis, namely, the determination
of the amino acid composition. 19 This was done by chromato
graphing the hydrolyzate from 2 mg.-samples of ribonuclease A
on buffered columns of the sulfonated polystyrene resin, Dowex
50-X4, 20 as is illustrated by the effluent curve shown· in Fig. 5.
In this curve, and in others somewhat like it that will be discussed
later, the horizontal axis gives the volume of eluent that has passed
through the column. The vertical axis gives the concentration of
amino acid in each small fraction of the effluent from the column,
as determined by a photometric ninhydrin method. 21 The area of
each peak on the curve is proportional to the quantity of amino
acid in the original mixture.
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The results of this chromatographic analysis were, in general,
in good agreement with the earlier findings of Brand, except for
the values for alanine and leucine. Assuming a molecular weight
of about 14,000, integral molar ratios were obtained for most of
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acid hydrolyzate of 2 mg. of ribonuclease A.19 The analysis was performed with
a 0.9 X 150-cm. column of Dowex 50-X4 and eluents of the indicated pH and
molarity.

the amino acids. The analytical results have had to be revised
slightly in the light of subsequent structural work, 22 which has
indicated that the original estimates for the decomposition during
hydrolysis of aspartic acid and of praline led to values that were
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high by one residue each. The empirical formula for ribonuclease
in terms of amino acid residues ( rather than the elements C, H,
and N) is given in Table 1. Such a formula is useful as a first
step in the determination of the structure of a protein. Note that
there are 14 residues of the basic amino acids, 4 arginines and 10
TABLE 1
AMINO Acm COMPOSITION OF RIBONUCLEASE*

Amino Acid
Aspartic acid
Glutamic acid
Glycine
Alanine
Valine
Leucine
Isoleucine
Serine
Threonine
Half-cystine
Methionine
Praline
Phenylalanine
Tyrosine
Histidine
Lysine
Arginine
Amide NH3
Total number of residues

Number of Residues
per Molecule
(mol. wt. 13,683)
15
12
3
12
9
2
3
15
10
8
4
4
3
6
4
10
4
(17)
124

* Ribonuclease from beef pancreas. 21, 22

lysines; that there are 8 half-cystine residues; and that several of
the amino acids-glycine, phenylalanine, leucine, and isoleucine,
for example-are present to the extent of only 2 to 4 residues per
molecule. The total number of amino acid residues is 124, which,
with 17 amide groups, and assuming the 124 residues to be pres
ent in one peptide chain, leads to a calculated minimal molecular
weight of 13,683.
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The fact that ribonuclease does contain but a single peptide
chain was shown by Dr. C. B. Anfinsen and his colleagues at the
National Heart Institute in Bethesda. By the use of the dinitro
phenyl technique of Sanger they succeeded in demonstrating that
the first four residues of this single chain had the sequence
Lys.Glu.Thr.Ala.-, starting at the amino-terminal end. 23 In
cluded in this lecture are frequent references to the work of Dr.
Anfinsen and his group, for his laboratory and our own have both
been working on the structure of ribonuclease, although our ap
proaches have been somewhat different. It is a pleasure to ac
knowledge the helpful interchange of information that has oc
curred throughout the course of these investigations.
Since ribonuclease does not appear to contain any sulfhydryl
groups, the single peptide chain must be held in a folded con
figuration by four disulfide bonds that join the eight half-cystine
residues. Following the general procedure utilized by Sanger in
his studies on the structure of insulin, these four disulfide bonds
were split by oxidation with peroxyformic acid. This procedure
does not separate peptide chains, as it does with insulin, but the
single folded chain of ribonuclease is opened up into a form more
readily hydrolyzed by proteolytic enzymes. In addition, the inter
pretation of the results of such proteolytic cleavage is easier if it
is no longer possible for different parts of the peptide chain to
be held together by the -S-S- bonds. Under properly chosen
experimental conditions, 24 peroxyformic acid almost quantitatively
converts the half-cystine residues to cysteic acid residues, and
methionine residues to the sulfone, without affecting any of the
other amino acids in ribonuclease. It is important to note that
ribonuclease fortunately does not contain tryptophan, which would
be oxidized by peroxyformic acid with the formation of a number
of products.
At this point we are ready to begin the determination of the
sequence of the 124 amino acid residues in the chain of oxidized
ribonuclease. This chain is too large to be studied as such; it must
first be reduced to fragments of a more manageable size. In the
work of Sanger and his colleagues on the sequence of the amino
acids in the oxidized A and B chains of insulin, partial hydrolysis
with HCI was the principal method used to split the long chains
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into peptides small enough for study. The products of this hy
drolysis were then separated by paper chromatography. As
Sanger 25 pointed out, however, it is doubtful whether hydrolysis
with concentrated HCI, which splits the peptide chain in a more
or less random manner, could be used effectively with larger
molecules. The complex mixture of peptides which would result
from the partial acid hydrolysis of a protein of the size of ribo
nuclease would be extremely difficult to fractionate. Moreover, the
deduction of a unique structure for the parent molecule becomes
progressively more difficult as the number of small fragments in
creases. It was decided, therefore, to use proteolytic enzymes
which, because of their specificity, cleave a protein into a limited
number of fragments. Enzymatic hydrolysis was used by Sanger
and his colleagues for the elucidation of parts of the structure of
insulin, and was subsequently employed by Bell and associates 5
and by Li and his group6 • in their work on the structure of
ACTH.
Of the readily available proteolytic enzymes, trypsin possesses
the sharpest specificity, as was demonstrated in the classic studies
of Bergmann, Fruton, and Hofmann°r . 2 s carried out with the aid
of synthetic substrates. On the basis of its specificity, trypsin
might be expected to hydrolyze oxidized ribonuclease at the pep
tide bonds involving the carboxyl groups of the 10 lysine and 4
arginine residues present in the molecule, to yield 14 or 15 frag
ments. Whether or not free lysine would be cleaved from the
amino-terminal position could not be foretold with assurance, nor
could the probability of the occurrence of trypsin-resistant lysyl
prolyl"bonds be predicted.
When about 200 mg. of oxidized ribonuclease were hydrolyzed
by trypsin and the products formed were separated by ion ex
change chromatography on columns of Dowex 50-X2, the results
shown in Fig. 6 were obtained. 22 Columns were used in these
studies in preference to paper chromatography, because quantita
tive data were desired, and because it was necessary to obtain 10mg. to 50-mg. quantities of the larger and more complicated
peptides in order to permit further structural work to be done.
As a first step in this structural work, quantitative amino acid
analyses were performed by ion exchange chromatography on an
7
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aliquot of the material in each peak. The results were particularly
informative in deciding whether or not a single peptide had been
obtained, for a reasonably well purified peptide should contain
only a limited number of amino acids in quantities that give in
tegral molar ratios. The amino acid composition of each peptide
obtained in relatively pure form is shown in Fig. 6. The sequence
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FrG. 6. Separation of the peptides present in a 20-hour tryptic hydrolyzate of
200 mg. of oxidized ribonuclease.22 A 2 X 150-cm. column of Dowex 50-X2
was employed. An additional peptide (No. 16) was eluted after a change at
4.5 liters to 2 N sodium acetate buffer at pH 6.6. The abbreviation Cys repre
sents a cysteic acid residue in the peptides from the oxidized protein.

of the residues in the brackets is not known. The numbers in
parenthesis give the yield of each peptide obtained after 3 and
after 20 hours of tryptic hydrolysis. On the basic of the specificity
of trypsin, the basic amino acid, lysine or arginine, is assigned to
the carboxyl-terminal position. It will be noted that peptide No.
10 contains two lysine residues. Inasmuch as DNP end-group
analyses of this peptide placed one lysine at the amino-terminal
position, it seems extremely probable that this fragment represents
the amino-terminal sequence. Since the first four amino acids of
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this sequence were shown by Anfinsen et al. 23 to be Lys.Glu.Thr.
Ala-, the finding of two more alanine residues and a lysine
makes it possible to extend this sequence to seven amino acids.
The amino acid analyses indicated that mixtures of peptides
were present in the zones marked 2, 3, 4, and 13+14, and
upon rechromatography under slightly different conditions, four
additional purified peptides were obtained. Three of them were
large, containing 19, 21, and 22 residues. Another peptide, No.
16, not shown in Fig. 6, was obtained at the end of the chromato
gram when the eluent was changed to a 2 N sodium acetate buffer
of pH 6.6. This peptide was also large, containing 20 amino acid
residues. It was devoid of lysine or arginine, however, and there
fore must have been derived from the carboxyl-terminal portion
of the chain.
It should be emphasized that the procedures that. have been
referred to are quantitative. The amino acid analyses help to in
dicate whether or not the peptides are pure, in the sense of
whether integral molar ratios for the constituents are obtained,
and if they are impure, the analyses may show the extent of the
contamination. Illustrative data are given in Table 2. In the
majority of cases, as can be seen from the table, only 5 to 10 per
cent or less of impurities were present, and the amino acid residues
that make up the peptide stand out clearly. From these data, the
yields given in Fig. 6 could be calculated, assuming each peptide
to occur only once in the parent protein.
As a result of the action of trypsin, thirteen peptides have been
obtained in yields of 50 to 100 per cent, and these account for all
of the 124 amino acid residues in oxidized ribonuclease. The com
positions of these peptides, and the high yields in which they were
isolated, indicate that transpeptidation by the enzyme is not occur
ring, and that such rearrangements will not complicate the inter
pretation of the results.
Clearly, the next step is to determine the order in which these
thirteen peptides are linked together, and for this purpose, it is
necessary to study the nature of the products formed when oxi
dized ribonuclease is cleaved at other sites by enzymes possessing
different specificities. To effect this cleavage, chymotrypsin and
pepsin have been used.
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Chymotrypsin does not possess as attractively high a degree of
specifi.y as does trypsin. A number of types of bond are split
at measurable rates, but there is a considerable preference for link
ages involving the carboxyl groups of phenylalanine, tyrosine,
TABLE 2
AMINO ACID COMPOSITION OF PEPTIDE FRACTIONS OBTAINED
FROM TRYPTIC HYDROLYSIS OF OXIDIZED R!BONUCLEASE22
Peptide

Amino Acid
Aspartic acid
Glutamic acid
Glycine
Alanine
Valine
Leucine
Isoleucine
Serine
Threonine
Cysteic acid
Methionine sulfone
Proline
Phenylalanine
Tyrosine
Histidine
Lysine
Arginine
Ammonia (amide)
Total number of
residues*

O-Tryp O-Tryp O-Tryp O-Tryp O-Tryp
2
4
6
7
5

3.06
2.10
0.99

0.02

0.95
2.84
2.85
2.01
0.95
1.97
0.06

3.15
2.07
0.03

2.09
0.01
0.08

6.31
0.96
1.13
2.98
0.96
1.14
0.99

1.10

0.95
1.00

0.04
0.08
0.24
0.11

0.06
0.03

1.01
0.95

1.00

0.04

2.23
0.91

1.06

0.07
0.07
0.03
0.17
0.05

0.06
0.04

0.03

0.95

0.97
(4.2)

(3.3)

(1.2)

19

21

5

0.07

0.14

0.09
0.03

0.06

1.05
-0.1

6

0.07

0.94
0.0

2

* Totals of boldface figures given in round numbers.

methionine ( and methionine sulfone), and leucine. As might be
expected, therefore, and as is evident from Fig. 7, the peptide
mixture obtained after 24 hours of hydrolysis by chymotrypsin21
is more complex than that obtained with trypsin. The yields are
also usually lower. Amino acid analyses indicated the presence of
mixtures of peptides in the regions of the curve marked 4+5,
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11 + 12, and 14+ 15 + 16. These were separated by rechromatog
raphy under different conditions of pH and temperature, as was
done before. A total of eighteen purified peptides, containing
from 3 to 27 amino residues each, were isolated from the chymo
tryptic hydrolyzate in yields of from 6 to 80 per cent. And finally,
additional although less complete data were secured through the
use of a third enzyme, pepsin. 28
[5er, Thr, Met]
(50%)
I (!NZ)
6

[Asp -l"mz, Glu -NH2
Ala, To[i,Lys] (f!i%)
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3.0
3.5
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4.5
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5.5
---0.
( 2Npl13.l-2.0Npl15.1), 35 tnroughou1-·------F1G. 7. Separation of the peptides in a 24-hour chymotryptic hydrolyzate of
oxidized ribonuclease.27
0

In all, the amino acid compositions of forty or more peptides
formed by the action of trypsin, chymotrypsin, and pepsin on oxi
dized ribonuclease have been established. What this very consider
able body of data can tell us about the structure of the molecule is
shown in Fig. 8. Here is given a partial structural formula for
oxidized ribonuclease that shows how the thirteen segments ob
tained by tryptic hydrolysis are linked together.
In Fig. 8 the chain has been divided into segments, which
should be imagined as being joined end to end. The residues en
closed within the parentheses in this formula are of undetermined
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sequence. The probable location of the amide groups in glutamine
and asparagine residues is indicated by the -NH 2 symbol, al
though this part of the scheme is the least certain. The peptides
formed by trypsin are labeled O-Tryp with a number correspond
ing to the numbering in Fig. 6, and are indicated by a solid line.
The 0- means they have been derived from oxidized ribonuclease.
Similarly, the chymotrypsin-peptides are indicated by the dashed
line, and the pepsin-peptides by the dotted line.
In deriving this scheme, three assumptions have been made.
These are: ( 1 ) That the amino acid residues are linked to one
another only through simple peptide bonds joining a-NH 2 and
a-COOH groups-that is, that the chain is unbranched. No evi
dence that branching occurs has yet been found. ( 2) That in pep
tides formed by the action of trypsin, an arginine or lysine residue,
if one is present, occupies the carboxyl-terminal position. And
( 3) that in peptides formed by the action of chymotrypsin, a tyro
sine or phenylalanine residue, if one is present, occupies the car
boxyl-terminal position. With these assumptions, the formula is
completely self-consistent and accommodates all of the data that
have been secured. Every peptide obtained fits-none have been
omitted. Finally, the scheme appears to be unique. No matter !).ow
we try, we cannot find another that will encompass all of the data.
The picture thus derived is also in accord with independent in
formation acquired by Redfield and Anfinsen.30
Let us go very briefly into the type of reasoning that has lecl to
this formulation. 27 Actually, one can start at any point and arrive
at the same picture, but it is most convenient to begin at the amino
end of the chain. It has already been shown that O-Tryp 10, with
its amino-terminal lysine, occupies the amino-terminal position in
the molecule. A key peptide found in both the chymotrypsin and
pepsin series of peptides is O-Chy 25. It has the same amino acid
composition as O-Tryp 10 with one Phe residue added. This Phe
is undoubtedly on the carboxyl end, which satisfies the specificity
requirements of both chymotrypsin and pepsin. It follows, there
fore, that the next peptide in the trypsin series that comes after
O-Tryp 10 must have amino-terminal Phe. There are only three
possibilities, because there are only three Phe residues in ribo
nuclease, and they are found in O-Tryp 9, 15, and 16. Peptide 16
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is excluded because, as we have seen, it is devoid of basic amino
acids and comes from the carboxyl end of the chain. O-Tryp 9 can
be eliminated because it was found, by the DNP technique, not to
contain amino-terminal Phe. This, by elimination, leaves O-Tryp
15 as the peptide following O-Tryp 10. Since O-Tryp 15 is a
tripeptide, and Phe is at one end and Arg at the other, its structure
is established and our accounting from the amino end has been
increased to ten residues.
We now turn back to the chymotrypsin series of peptides. The
placing of O-Tryp 15 requires the next chymotrypsin peptide to
begin with the sequence Glu-Arg-. There are only four O-Chy
peptides that contain glutamic acid and arginine, namely, O-Chy
14, 21, 22, and 27. O-Chy 14 and O-Chy 27 can be eliminated
because if they were placed in this position, their amino acid com
position would make it impossible for any remaining peptide of
the trypsin series to follow O-Tryp 15. This leaves only O-Chy
21 and 22, which have so similar and unique an amino acid com
position-each contains much Ser, one Met, and one His-that it
can be decided that they come from the same part of the molecule.
The two are placed in the manner indicated in Fig. 8. This
uniquely defines the beginning of the trypsin peptide that follows
O-Tryp 15. O-Tryp 4 is the only one that contains Met, His, and
six serines and hence must be the next segment in the chain.
Without further pursuing this crossword puzzle type of occupa
tion here, it can be stated that by alternating between the peptides
of the trypsin and the chymotrypsin series, and occasionally calling
on the pepsin experiments when necessary, it is possible to assem
ble the complete scheme shown in Fig. 8.
What amounts to almost clinching evidence in favor of this
structure has come from experiments in which the larger trypsin
FIG. 8. A partial structural formula for oxidized ribonuclease.27 The amino
acids are considered to be arranged in a single chain with the segments in the
figure joined end to end. The formula is based upon the study of the peptides
liberated by tryptic, chymotryptic, and peptic hydrolysis of the oxidized protein.
The tentative allocation of amide groups (-NH2) has been based upon the
most recent results, which have permitted definite placement of some of the
asparaginyl and glutaminyl residues.29 The residues in parentheses are of unde
termined sequence.
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peptides, Nos. 4, 9, 2, and 16, have been isolated and then hydro
lyzed with chymotrypsin. In each case, peptides of the expected
amino acid composition have been isolated from the hydrolyzate.
This partial structural formula of ribonuclease serves several
useful purposes. In the first place, although it is only a partial
formula, it still reveals much about the way the enzyme is put
together. None of the unknown sequences are longer than eight
amino acid residues, and many are shorter. In the second place, the
formula serves as a guide for further work. It permits three more
or less independent investigations connected with the detailed
structure of the enzyme to proceed simultaneously. These are: the
determination of the complete sequence of the amino acid residues
in the oxidized protein; the determination of the positions of the
four disulfide bonds in the native protein, or in other words, find
ing out which pairs of half-cystine resid1:1es were linked together
before oxidation split them apart; and finally, the study of whether
any particular portion of the entire large molecule is responsible
for its enzymatic activity-briefly that is, whether ribonuclease has
a so-called "active center," and if it does, where this "active
center" is located. Let us take up these questions in order.
Because the manner is already known in which the forty or
more peptides formed by enzymatic hydrolysis are linked, detailed
sequence studies of all of these peptides are not required. Only
those are selected for sequence work that do not overlap one
another and that are of a suitable size. The thirteen peptides of
the trypsin series were the starting products. The nine smallest
could be studied directly, but the four larger ones, 0-Tryp 4, 9, 2,
and 16, were first hydrolyzed with chymotrypsin to give fourteen
smaller fragments.
In determining the sequence of amino acids in all of these pep
tides, the phenylthiocarbamyl technique of Edman has been the
principal procedure employed by Dr. Hirs. The reaction permits
residues to be removed one at a time from the amino end of a
peptide. The cleavage frequently is not quantitative, however, and
carefully performed amino acid analyses at each stage of the deg
radation are required to permit clear-cut interpretation of the
results.
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In addition to the Edman procedure, Dr. Hirs has been using
two enzymatic methods of degradation. These employ carboxy
peptidase, which splits amino acids from the carboxyl end of
peptides, and leucine aminopeptidase, prepared according to
Spackman, Smith, and Brown, 31 which acts in the same way at the
opposite, or amino, end. By performing quantitative determina
tions of the free amino acids released after varying periods of
enzymatic action, the sequence of amino acids at either the car
boxyl or amino end of the peptide may frequently be inferred.
Since the basic amino· acid residues are split off only with difficulty
by carboxypeptidase, the hydrazinolysis method of Akabori and
associates has been used to con.firm the presence of carboxyl
terminal lysine. The enzymatic methods have the advantage that
asparagine and glutamine residues are liberated as such, without
hydrolysis of the sensitive {3- or y-amide bond.
Sequence work of this kind is slow. Each peptide must be pre
pared in adequate amounts, and its purity in terms of amino acid
composition established before further work can proceed. Never
theless, by a combination of techniques, Dr. Hirs has thus far
established or confirmed the position of about half of the residues
in oxidized ribonuclease. The results to date ( Hirs 29 ) are shown
in Fig. 9. The sequence of the first ten residues has been con
firmed. The tetrapeptide sequence at O-Tryp 11, originally de
termined by Redfield and Anfinsen30 has also been confirmed, and
the order of the eight amino acids preceding it has been estab
lished. Another sequence around the fourth and fifth half-cystine
residues has been worked out, and near the carboxyl end of the
chain a sequence of twenty-one amino acid residues has been de
termined. The sequence of the four amino acids at the carboxyl
end has been established by Anfinsen and associates. 2 •
While this sequence work has been proceeding, Dr. D. H.
Spackman in our laboratory, and Drs. A. P. Ryle and C. B. An
finsen have been attempting to determine which pairs of half
cystine residues ( numbered 1 to 8 in Fig. 9) are connected by
disulfide bonds. The problem is basically similar to the one al
ready solved by Sanger and his colleagues in their work on insulin.
Since ribonuclease in which the disulfide bonds are intact is not
3 30
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hydrolyzed in simple aqueous solution by trypsin or chymotrypsin,
Dr. Spackman has allowed enzymatic action to proceed in 2 M
guanidinium chloride.
The hydrolyzate obtained by tryptic plus chymotryptic cleavage
of unoxidized ribonuclease was chromatographed on Dowex
50-X2, and from two of the cystine-containing zones from the
chromatogram, two pairs of cysteic acid-containing peptides were
isolated. 3 2 One pair was (CyS03 H, Asp--NH2 , Glu-NH2 ,
MetS0 2 ) and (CyS03 H, Asp, Ileu, Thr, Ser, Arg), and the other
was (Asp-NH2, CySOaH, Ala, Val, L'ys) and (CyS0 3 H,
Asp-NH 2 , Asp-NH2, Glu-NH2, Gly, Thr, Tyr). From the
Lys.Glu. Thr.Ala.Ala.Ala.Lys.Phe.Glu.Arg.(Asp,Glu,Thr,Sers,Met,His).(i) NH2 NH2
NH2
NH2
I
I I
I
I
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NH2
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I
I
I
Asp.Arg.(Cys,Asp,Val,Pr0,Thr,Lys).Phe.(Glu,Val,Leu,Ser,His).-
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1
(Cys,Asp,Glu,Gly,Ala,Pro).Tyr.(Val2.Pro,His).Phe.Aso.Ala.Ser.Val
FIG. 9. Arrangement of the amino acid residues in oxidized ribonuclease
(Hirs) .29 The sequences determined to date are underlined. The residues in
parenthesis are of undetermined order. The cysteic acid residues have been num
bered consecutively, 1 to 8, starting from the amino end of the chain.
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amino acid compositions of these peptides, without the per
formance of any sequence studies, it could be concluded that one
disulfide bond links half-cystine residues 1 and 6, and another
unites residues 4 and 5. Ryle and Anfinsen, proceeding in a differ
ent manner, have also obtained evidence in favor of a 4-5
-S-S- bond. There are still two more to be located, and very
recently, Dr. Anfinsen has kindly informed us that they have
secured evidence 33 indicating a linkage between half-cystines 2 and
8, and 3 and 7. As a result of these experiments, all four of the

2
FIG. 10. A two-dimensional diagram indicating the positions of the four
disulfide bonds in native ribonuclease (based upon the results of Spackman
et al.32 and Ryle and Anfinsen33 ).

disulfide bonds would appear to be accounted for, and from their
arrangement, it is clear that the peptide chain in ribonuclease is
tightly tied together. This (through Dr. Anfinsen's courtesy in
letting us include his data) is shown schematically in two dimen
sions in Fig. 10. One feature of the molecule is readily apparent
from Figs. 9 and 10. Although the sequence around the 4-5
disulfide link has not yet been completely worked out, there is
no doubt that the small disulfide ring in this part of the molecul�
is about equivalent in size to the one already found in insulin and
also in the peptide hormones, vasopressin and oxytocin.
As mentioned previously, the partial structural formula of
ribonuclease (Fig. 8) is extremely useful as a guide in studies
designed to learn more about the so-called "active center" of this
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enzyme. The general problem of "active sites" is one of the most
important in protein chemistry, because, of course, one of the
main reasons for determining the structure of an enzyme is the
hope that, in this manner, some insight will be gained into the
basis for its catalytic properties. In research directed toward this
end, Anfinsen34 has found that even minimal hydrolysis of ribo
nuclease by pepsin abolishes enzymatic activity. Dr. F. M.
Richards, now at Yale University, has observed that, after mild
hydrolysis by the bacterial proteinase subtilisin, a new active peak
appears upon chromatography of the hydrolyzate on columns of
IRC-50. 35 Dr. M. Uziel, in our laboratory, has been approaching
the problem by studying the action of trypsin on ribonuclease in
2 M guanidinium chloride. Ribonuclease is still active under these
conditions, as Anfinsen 36 found it to be in 8 Af urea, and attempts
are now in progress to isolate active but altered products from such
tryptic hydrolyzates. Since bonds at which trypsin may cleave the
oxidized molecule are known (Fig. 8), the interpretation of the
results of partial tryptic hydrolysis of "native" ribonuclease should
be facilitated.
This takes us as far as we can go at present in our structural
analysis of ribonuclease. The completion of the task does not look
as if it would present major difficulties, but it should be empha
sized that one must always be on the lookout for surprises. Al
though all that has been learned about ribonuclease so far is in
accord with the working hypothesis that the molecule contains a
single unbranched peptide chain, an experimenter must be pre
pared to encounter unexpected linkages in proteins-linkages of
the type that Craig and his colleagues encountered in bacitracin,
for example.
It is fair to ask, at this point, whether we have learned anything,
in general, about the structure of proteins. We certainly do not yet
know why ribonuclease is an enzyme. Moreover, examination of
the structure of insulin, ACTH, glucagon, and ribonuclease has
not yet revealed any common plan for the arrangement of the
amino acid residues. Nor can we deduce anything about the
nature of the metabolic machinery that synthesizes these proteins,
except that it is amazingly precise and has not yet been found to
make a mistake. A valine has never been found where a leucine
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usually goes, for example. Each molecule of bovine ribonuclease
appears to be like each other molecule, just as is the case for in
sulin from a given species.
Proteins are so complex in structure, so numerous, and ex
hibit such diverse activities, that we cannot expect the many prob
lems they raise to be solved by the incomplete information we now
possess. Current knowledge of proteins is still relatively small;
learning how to learn has been a major objective of the research
thus far. It is hoped that the method of approach initiated by
Sanger and expanded in the work on ribonuclease will also be gen
erally applicab]e to larger and more complex molecules, for it is
obviously going to be necessary to know the formulas of many
proteins of different origins and different functions if we are to
understand the many biochemical reactions in which proteins par
ticipate. The approach that has been outlined in this lecture de
pends heavily upon amino acid analysis, with particular emphasis
upon the acquisition of quantitative data. The liberal use of amino
acid analysis renders the approach quite general, since the same
method of analysis is applicable to all proteins and peptides, no
matter how different they may be. The quantitativeness of the
procedures is important. When working with molecules as large
and complex as the proteins, it is, in our experience, hard to over
estimate the extent to which progress is expedited and error
avoided by the availability of dependable quantitative data.
It is obvious, however, that this scheme is only feasible if a
relatively quick, simple, and accurate method of amino acid analy
sis is at hand. In order to fulfill this need, automatic recording
equipment has recently been devised with the skillful collabora
tion of Dr. Spackman-equipment that permits a complete quanti
tative analysis to be turned out every 24 hours with a minimum of
labor.37 This new technique has been of great value in the later
phases of the work on ribonuclease, and it is hoped that it will
catalyze further advances in our general knowledge of the struc
ture of proteins. This, of course, is only one new development in
a field that is expanding so rapidly that we feel sure that future
Harvey Lecturers will be able to give us much more definitive
information about Nature's most intricate molecular design-the
proteins.
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